Brief: Telo Genomics Announces Final Assignment Of Patents On Hematological Cancers, Liquid Biopsy & Alzheimer's Disease
11/11/2020 19:27
Nov 11 (Reuters) - Telo Genomics Corp TELO.V :
* TELO GENOMICS ANNOUNCES THE FINAL ASSIGNMENT OF PATENTS ON
HEMATOLOGICAL CANCERS, LIQUID BIOPSY AND ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNX2DzWFQ
Further company coverage: TELO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telo Genomics
See all newsBrief: Telo Genomics Announces Positive Results Of Smoldering Multiple Myeloma Proof Of Concept Study
Brief: Telo Genomics Announces Final Assignment Of Patents On Hematological Cancers, Liquid Biopsy & Alzheimer's Disease
Brief: Telo Genomics Announces Multiple Myeloma Collaboration With Mayo Clinic
Brief: 3D Signatures Announces Name Change To Telo Genomics Corp
Brief: 3D Signatures Says Current Board And Executive Management Team Do Not Intend To File For Bankruptcy